| Document |
Document Title |
|
WO/2007/077140A1 |
The present invention relates to derivatives of tert-butoxy-norephedrine and/or -ephedrine and also to processes for their preparation. The invention additionally relates to processes for preparing 4-hydroxy-norephedrine, especially 4-hy...
|
|
WO/2007/074068A1 |
The invention relates to a method for producing optically active, aromatically substituted amino ethanol of general formula (IIa) or (IIb), by reacting the corresponding chloroethanol of formula (Ia) or (Ib) with ammonia.
|
|
WO/2007/074047A1 |
Method for producing the O-alkylated aminoalcohols of formula (I) by reacting N-unsubstituted or N-monosubstituted aminoalcoholate salts with alkyl halides, the aminoalcoholate salts being formed by alcoholates.
|
|
WO/2007/076392A2 |
A method for reusing rhenium from a donor spent epoxidation catalyst, the method comprising: providing a donor comprising spent epoxidation catalyst comprising rhenium, the donor having a cumulative alkylene oxide production of 0.16 kT/m...
|
|
WO/2007/076390A2 |
A process for preparing a rejuvenated epoxidation catalyst, for the epoxidation of one or more olefins using the rejuvenated epoxidation catalyst to produce olefin oxide, and for the production of a 1,2-diol, a 1,2-diol ether, or an alka...
|
|
WO/2007/074046A2 |
Method for producing O-alkylated aminoalcohols by reacting N-unsubstituted or N-monosubstituted aminoalcoholates with alkyl halides, the aminoalcoholates being formed by means of alkali hydroxides or alkaline earth hydroxides.
|
|
WO/2007/071404A1 |
Desvenlafaxine is formed from venlafaxine by the use of a demethylating agent comprising a metal sulfide, such as sodium sulfide, and optionally selenium.
|
|
WO/2007/068324A1 |
The present invention discloses a process for the preparation of atomoxetine hydrochloride in a pure crystalline form, characterised by an XRPD spectrum as in (Fig 1). It is also object of the present invention to provide methods to obta...
|
|
WO/2007/069277A2 |
A process for preparing venlafaxine hydrochloride and also a process for preparing l-[2-amino- l-(4-methoxy phenyl)ethyl]cyclohexanol hydrochloride, an intermediate of venlafaxine hydrochloride are disclosed. p-Methoxy phenyl acetonitril...
|
|
WO/2007/067501A1 |
A process for the enantio selective synthesis of an (S)- or (R)- l-[2- dimethylamino)-l-(methoxyphenyl)ethyl]cyclohexanol and analogues or salt thereof are described. The method involves the steps of (a) reacting an (S) or (R) 4- benzylo...
|
|
WO/2007/060122A1 |
The present invention relates to a process for preparing 3 amino-3-methyl-1-butanol (I) by, in a first step, reacting 3-methylbut-3-en-1-ol (IIa) or 3-methylbut-2-en-1-ol (IIb) with a nitrile of the formula (III) in the presence of an ac...
|
|
WO/2007/057120A1 |
The invention relates to a process in which a compound R1COOR3 (I) is made by a transesterification reaction of an ester compound R1COOR2 (II) with an alcohol R3OH (III) in the presence of a transesterification catalyst, wherein R1 is H ...
|
|
WO/2007/059350A2 |
Embodiments of the process for the preparation of alkoxyamines of the present invention are directed to conducting a coupling reaction in a reaction medium initially comprising at least one transition metal catalyst, an ATRP initiator an...
|
|
WO/2007/055180A1 |
Disclosed is a method for producing an optically active trans-2-aminocyclohexanol represented by the general formula (2) below or a protonic acid salt thereof. The method is characterized in that an optically active trans-2-benzylaminocy...
|
|
WO/2007/053755A1 |
Disclosed is a process for preparing substituted anisidines of formula I starting from substituted cyclic hydroxy-ketones II via aromatization through a substituted oxime intermediate IV in which R is C1-C6 alkyl or halogen, and Alk is C...
|
|
WO/2007/053730A1 |
The present invention relates to processes for the preparation of (ω- aminoalkylainino)alkyl halides, their conversion to S-ω-(ω-aminoalkylamino)alkyl phosphothioates, and purification of the crystalline products of the reaction. The ...
|
|
WO/2007/051576A1 |
Compounds of the formula (II) can be hydrogenated to the corresponding butane derivatives in the presence of homogeneous catalysts comprising metal salts or complexes containing metals from the group consisting of Rh, Ir and Ru and prefe...
|
|
WO/2007/046001A2 |
Described is a process of preparing a pure solid or crystalline racemic 3,3- diarylpropylamine compound and the compounds formed thereof. The solid and crystalline forms of racemic 3,3-diarylpropylamine compound are especially suitable f...
|
|
WO/2007/047972A2 |
The invention encompasses processes for the preparation of highly pure venlafaxine hydrochloride, l-[2-dimethylamino-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride as well as intermediates thereof.
|
|
WO/2007/045857A1 |
The present invention relates to processes for the preparation of 4- hydroxy-α' -[[[6-(4-phenylbutoxy)hexyl]amino]methyl]- 1,3-benzenedimethanol 1-hydroxy-2-naphthoate (salmeterol xinafoate) (Formula (12a)), the preparation of 4-hydroxy...
|
|
WO/2007/039918A1 |
The present invention relates to a novel and improved process for the preparation of tolterodine of formula I. Key steps involved in the process are a vinyl Grignard reaction on a benzophenone derivative of formula XXI to get the vinyl c...
|
|
WO/2007/036496A1 |
A method for preparing aminodiglycol (ADG) and morpholine by reaction of diethyleneglycol (DEG) with ammonia in the presence of a transition metal heterogeneous catalyst is characterised in that the catalytically active mass of the catal...
|
|
WO/2007/030587A1 |
The present invention provides improved processes for the preparation of atomoxetine hydrochloride under reaction conditions that improve reaction yields and facilitate commercial synthesis, m particular, the invention is directed to the...
|
|
WO/2007/026513A1 |
Disclosed is a fluoroether compound having a terminal alkylamino group represented by the following general formula: RfO[CF(CF3)CF2O]mCF(CF3)(CH2)nNR1R2 (wherein Rf represents a perfluoro lower alkyl group, R1 represents an alkyl group h...
|
|
WO/2007/022030A2 |
The present invention provides methods of carrying out the safe and reliable preparation of lipids comprising quaternary amines. Such lipids are especially suited for introducing therapeutic agents into cells or organisms. In particular,...
|
|
WO/2007/020381A2 |
A process for the preparation of a compound of formula (I) wherein: R is an alkynyl group; R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, it being possible in turn for all of the receding groups to c...
|
|
WO/2007/018817A2 |
Alkanolamine compositions are disclosed. The composition comprises an alkanolamine and hydroxylamine or hydrazine. Preferred alkanolamine includes diethanolamine, triethanolamine, and mixtures thereof. The composition of the invention ha...
|
|
WO/2007/009405A1 |
Racemic N-benzyl-N-methyl-3-(2-methylphenoxy)-3-phenylproρylamine (VIII) is an intermediate for obtaining atomoxetine. Racemic N-benzyl-N-methyl-3-(2-methylphenoxy)-3- phenylpropylamine (VIII) further reacts in a solution of an organic ...
|
|
WO/2007/010082A1 |
The invention relates to the use of copper-catalyzed nucleophilic aromatic substitution reaction for preparing 3-aryloxy-3-arylpropylamines and more specifically to a method of preparing certain 3-aryloxy-3-arylpropylamines and the pharm...
|
|
WO/2007/010350A1 |
This invention is directed to a method of synthesizing compounds of Formula (I) and to intermediates useful in the synthesis of compounds of Formula (I): wherein X, Y, R1, R2, R3, and R4 are as defined herein above.
|
|
WO/2007/006132A1 |
Provided is an efficient method for the preparation of 3-aryloxy-3- arylpropylamines, their optical stereoisomers, and pharmaceutically acceptable salts thereof. The process allows for the isolation of 3-aryloxy-3- arylpropylamines in hi...
|
|
WO/2007/007828A1 |
Disclosed is a novel compound useful as a production intermediate for benzylamine derivatives. Also disclosed is a method for producing such a compound. Specifically disclosed is a method for producing an ethylenediamine derivative repre...
|
|
WO/2007/000945A1 |
Disclosed is a method for producing a molded catalyst for continuous production of a mono(lower alkyl)monoalkanolamine wherein a binder is added into a catalyst raw material containing a crystalline metallosilicate and/or a layered clay ...
|
|
WO/2007/000918A1 |
Benzylamine derivatives having structures represented by the general formula (1): (1) a method for the optical resolution of benzylamine derivatives which comprises using optically active mandelic acid as the reagent for optical resoluti...
|
|
WO/2006/126846A1 |
This invention relates to a method for preparing tetrafluorobenzyl-5-aminosalicylic acid derivative and its pharmaceutically acceptable salt compounds. In particular, this invention relates to a method for preparing tetrafluorobenzyl-5-a...
|
|
WO/2006/125675A1 |
The invention relates to a method for isolating a stereoisomer from a mixture comprising two stereoisomers of general formulas (I-A) and (I-A') and/or two stereoisomers of general formulas (I-B) and (I-B'), wherein R1, R2, and R3 are ide...
|
|
WO/2006/124283A1 |
Disclosed are methods for making 1,3- and 1,4-diamino-phenyl intermediates by utilizing bis-amination of ortho-substituted aryl halides.
|
|
WO/2006/123672A1 |
Disclosed is a method for commercially producing an aminoalcohol derivative (I) having a biphenyl group. Also disclosed are a biphenyloxyacetaldehyde derivative used therefor, a method for producing such a biphenyloxyacetaldehyde derivat...
|
|
WO/2006/121187A1 |
The present invention provides: an acrylicester compound having a structure represented by General Formula (1) or (2) below ; a latent electrostatic image forming member includes a cured material obtained through a radical polymerization...
|
|
WO/2006/108120A1 |
Stable Atomoxetine hydrochloride, a process for the manufacture thereof, the use of stable Atomoxetine Hydrochloride for making a pharmaceutical formulation, a process for the preparation of any form of Atomoxetine Hydrochloride, and an ...
|
|
WO/2006/107134A1 |
The present invention provides a method for preparing valienamine from acarbose or acarbose derivatives by using a base. The present invention provides an improved method for preparing valienamine compared to conventional preparation met...
|
|
WO/2006/097744A2 |
The present invention provides the use of a compound of the Formula: (I) wherein R1 is C1-5 alkoxy, OCOC1-3Alkyl, O(CH2)2O(CH2)2O(CH2)2OMe, O(CH2)2O(CH2)2O(CH2)2OH or OH; R2 is H, (CH2)nOH, OCH3, Hal or (II) or (III) R3 is H or (CH2)nOH;...
|
|
WO/2006/091301A2 |
Protecting the security of an entity by using passcodes is disclosed. A passcode device 101 generates a passcode Pi. In an embodiment, the passcode Pi is generated in response to receipt of user information. The passcode Pi 1 is received...
|
|
WO/2006/090264A1 |
The present invention relates to an improved process for preparing 2-amino-5-protected-amino-3-hydroxy-1,6-diphenylhexane compounds or acid addition salts thereof, which can be useful intermediates for preparing compounds with antiviral ...
|
|
WO/2006/091705A2 |
Disclosed are compounds represented by structural formula (I): methods of producing compounds represented by structural formula (I), and their use in inhibiting oxidation in an oxidizable material.
|
|
WO/2006/088525A1 |
Methods for the preparation of stereoisomerically substantially aminocyclohexyl ether compounds such as trans-(1R,2R)-aminocyclohexyl ether compounds and/or trans-(1S,2S)-aminocyclohexyl ether compounds as well as various intermediates a...
|
|
WO/2006/087166A1 |
Provided is a process for the preparation of N-monosubstituted β-aminoalcohol sulfonates of formula (Ia), (Ib) wherein R1 is C6-20 aryl or C4-12 heteroaryl, each optionally being substituted with one or more halogen atoms and/or one or ...
|
|
WO/2006/085493A1 |
An aromatic diamine represented by the following formula (I): (wherein R1 to R6 each independently represent hydrogen, an alkyl group or an aryl group and may be the same or different). The aromatic diamine is useful as a curing agent fo...
|
|
WO/2006/082200A1 |
The invention relates to a method for preparing amino-alcohols and alcohols in a simple and low-cost manner by directly reducing amino-acids, carboxylic acids and corresponding esters with the aid of a novel nondangerous reducing entity ...
|
|
WO/2006/079090A2 |
Methods and inte&pgr nediates for the preparation of Fenoldopam mesylate and ntermediates thereof are provided.
|
